← All stocks

CVS Health

CVS Net selling
CIK 0000064803 #141 in the set updated 17 Sep 2026
Bought (120 mo)
$8.46M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$928.33M
$0.00 on a plan · $327.10M straight out of an exercise
Sold at will
$601.23M
33 of 114 sales
Net
−$919.87M
−$592.77M against sales at will

By person

56 insiders · 138 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
ROBBINS LARRY
Director
$571.17M (13)
−$571.17M
4,824,799
$450.87M
−59.6%
MERLO LARRY J
Director
$93.24M (7) scheduled
−$93.24M
632,313
$59.09M
+42.6%
Moriarty Thomas M
EVP & General Counsel
$66.76M (14) scheduled
−$66.76M
333,499
$31.16M
Denton David M
EVP and CFO
$47.05M (6) scheduled
−$47.05M
403
$37.66K
−99.8%
Roberts Jonathan C
EVP & Chief Operating Officer
$44.39M (7) scheduled
−$44.39M
426,025
$39.81M
Brennan Troyen A
EVP and Chief Medical Officer
$30.99M (12) scheduled
−$30.99M
232,676
$21.74M
+119.1%
Lotvin Alan
EVP&President-PharmacyServices
$315.68K (1)
$19.14M (7) scheduled
−$18.82M
109,183
$10.20M
Finke Daniel P
EVP/Pres, Health Care Benefits
$10.35M (6) scheduled
−$10.35M
35,068
$3.28M
−20.1%
Foulkes Helena
EVP & President-CVS Pharmacy
$7.83M (4) scheduled
−$7.83M
45,107
$4.22M
+253.2%
Mandadi Tilak
EVP, Chief Exp & Tech Officer
$6.23M (1)
−$6.23M
10,133
$946.91K
Bisaccia Lisa
Former EVP & Chief HR Officer
$5.87M (4) scheduled
−$5.87M
66,417
$6.21M
+100.5%
Shah Prem S
EVP and Group President
$5.10M (9) scheduled
−$5.10M
64,356
$6.01M
Lynch Karen S
President and CEO
$976.57K (1)
$6.01M (1)
−$5.03M
506,079
$47.29M
Clark James David
SVP, Cont & Chief Acct Officer
$4.20M (9)
−$4.20M
27,606
$2.58M
+3,076%
Boratto Eva C
EVP & CFO
$4.19M (6) scheduled
−$4.19M
115,331
$10.78M
+125.9%
Flum Joshua Matthew
EVP, ENT STRATEGY & DIGITAL
$2.62M (2) scheduled
−$2.62M
25,657
$2.40M
+5.3%
Mahoney Michael F
Director
$2.50M (2)
+$2.50M
45,701
$4.27M
+26,015%
DORMAN DAVID W
Director
$2.02M (2)
+$2.02M
109,875
$10.27M
+247.8%
BROWN C DAVID II
Director
$1.15M (2)
+$1.15M
129,316
$12.08M
+41.7%
Sussman Andrew
EVP, Clinical Services
$1.13M (2) scheduled
−$1.13M
16,433
$1.54M
+1.0%
LUDWIG EDWARD J
Director
$1.09M (7)
+$1.09M
21,630
$2.02M
Mayhew Jonathan E.
EVP - Transformation
$686.14K (1)
−$686.14K
6,855
$640.59K
−64.1%
Hourican Kevin
EVP & President, CVS Pharmacy
$642.30K (1) scheduled
−$642.30K
15,237
$1.42M
−1.7%
Finucane Anne A.
Director
$532.65K (1)
−$532.65K
22,747
$2.13M
+20.0%
AGUIRRE FERNANDO
Director
$300.59K (2)
+$300.59K
10,513
$982.42K
SWIFT RICHARD J
Director
$199.05K (1)
−$199.05K
7,336
$685.54K
+46.1%
SANSONE GUY P
Director
$100.01K (1)
+$100.01K
15,106
$1.41M
+145.2%
CAPOZZI HEIDI B
EVP and Chief People Officer
$4.59K (3)
+$4.59K
13,108
$1.22M
Nelson Steven H
EVP and President, Aetna
$1.29K (1)
+$1.29K
2,924
$273.24K
PELUSO MICHELLE A
EVP and Co-President of Retail
124,383
$11.62M
+126.0%
Kraft Robert O.
EVP and President - Omnicare
92,360
$8.63M
+8.5%
Joyner J. David
President, CEO and Chair
70,349
$6.57M
GOLD STEPHEN J
EVP & CIO
46,818
$4.38M
+38.8%
COWHEY THOMAS F.
EVP and CFO
41,109
$3.84M
+123.8%
WHITE TONY L
Director
37,852
$3.54M
+85.1%
GUERTIN SHAWN M
EVP & Chief Financial Officer
34,706
$3.24M
DEPARLE NANCY ANN
Director
34,169
$3.19M
+487.6%
Khichi Samrat S.
EVP, CPO and General Counsel
33,421
$3.12M
Montgomery Neela
EVP and Pres., Pharmacy/Retail
29,502
$2.76M
Rice Derica W
EVP & President, CVS Caremark
26,827
$2.51M
+62.2%
Chaguturu Sreekanth K
EVP and Chief Medical Officer
23,666
$2.21M
FARAH ROGER N
Director
19,438
$1.82M
Balser Jeffrey R.
Director
15,717
$1.47M
+7,110%
BRACKEN RICHARD M
Director
15,348
$1.43M
+290.8%
KIRBY J SCOTT
Director
14,434
$1.35M
Bertolini Mark T
Director
13,773
$1.29M
Kane Brian A
EVP/President, Aetna
12,569
$1.17M
Compton-Phillips Amy
EVP, Chief Medical Officer
9,557
$893.08K
Havanec Laurie P.
EVP and Chief People Officer
9,426
$880.84K
SCHAPIRO MARY L
Director
7,585
$708.80K
Norwalk Leslie V
Director
7,376
$689.27K
Shulman Douglas H.
Director
5,929
$554.05K
MILLON JEAN PIERRE
Director
4,514
$421.83K
Newman Brian
EVP, Chief Financial Officer
3,008
$281.09K
DECOUDREAUX ALECIA A
Director
2,970
$277.54K
Gallina John E
Director
582
$54.39K

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Insider
Date
Role
Action
Shares
Price
Amount
Clark James David
5 Mar 2025
SVP, Cont & Chief Acct Officer
Sold after exercise
7,513
$66.35
$498.49K
Moriarty Thomas M
15 Dec 2022
EVP & General Counsel
Sold after exercise
36,490
$98.24
$3.58M
Moriarty Thomas M
15 Dec 2022
EVP & General Counsel
Sold after exercise
100,976
$98.40
$9.94M
Lotvin Alan
4 Aug 2022
EVP&President-PharmacyServices
Sold after exercise
22,541
$104.00
$2.34M
Finke Daniel P
3 Aug 2022
EVP/Pres, Health Care Benefits
Sold after exercise
9,546
$100.00
$954.60K
Lotvin Alan
3 Aug 2022
EVP&President-PharmacyServices
Sold after exercise
50,501
$98.00
$4.95M
Lotvin Alan
3 Aug 2022
EVP&President-PharmacyServices
Sold after exercise
70,398
$98.00
$6.90M
Moriarty Thomas M
28 Jun 2022
EVP & General Counsel
Sold after exercise
38,873
$95.00
$3.69M
Moriarty Thomas M
28 Jun 2022
EVP & General Counsel
Sold after exercise
50,502
$95.00
$4.80M
Moriarty Thomas M
28 Jun 2022
EVP & General Counsel
Sold after exercise
49,279
$95.00
$4.68M
Shah Prem S
8 Apr 2022
EVP and Co-President of Retail
Sold after exercise
3,130
$105.00
$328.65K
Shah Prem S
8 Apr 2022
EVP and Co-President of Retail
Sold after exercise
4,103
$105.00
$430.82K
Shah Prem S
8 Apr 2022
EVP and Co-President of Retail
Sold after exercise
5,719
$105.00
$600.50K
Shah Prem S
8 Apr 2022
EVP and Co-President of Retail
Sold after exercise
3,157
$105.00
$331.49K
Shah Prem S
8 Apr 2022
EVP and Co-President of Retail
Sold after exercise
845
$105.00
$88.73K
Finke Daniel P
4 Apr 2022
EVP/Pres, Health Care Benefits
Sold after exercise
12,032
$100.13
$1.20M
Finke Daniel P
4 Apr 2022
EVP/Pres, Health Care Benefits
Sold after exercise
27,166
$100.13
$2.72M
Finke Daniel P
4 Apr 2022
EVP/Pres, Health Care Benefits
Sold after exercise
16,161
$100.13
$1.62M
Shah Prem S
30 Mar 2022
EVP and Co-President of Retail
Sold after exercise
5,346
$104.70
$559.73K
Shah Prem S
17 Mar 2022
EVP and Co-President of Retail
Sold after exercise
2,935
$106.65
$313.02K
Shah Prem S
17 Mar 2022
EVP and Co-President of Retail
Sold after exercise
1,689
$106.65
$180.13K
Moriarty Thomas M
15 Mar 2022
EVP & General Counsel
Sold after exercise
51,361
$105.00
$5.39M
Brennan Troyen A
3 Feb 2022
EVP and Chief Medical Officer
Sold after exercise
47,937
$110.00
$5.27M
Lotvin Alan
1 Feb 2022
EVP&President-PharmacyServices
Sold after exercise
21,386
$106.50
$2.28M
Clark James David
28 Jan 2022
SVP, Cont & Chief Acct Officer
Sold after exercise
6,059
$109.00
$660.43K
Roberts Jonathan C
27 Jan 2022
EVP & Chief Operating Officer
Sold after exercise
68,482
$107.50
$7.36M
Roberts Jonathan C
3 Nov 2021
EVP & Chief Operating Officer
Sold after exercise
108,870
$95.00
$10.34M
Brennan Troyen A
1 Nov 2021
EVP and Chief Medical Officer
Sold after exercise
28,159
$90.00
$2.53M
Brennan Troyen A
26 Oct 2021
EVP and Chief Medical Officer
Sold after exercise
80,802
$88.00
$7.11M
Brennan Troyen A
26 Oct 2021
EVP and Chief Medical Officer
Sold after exercise
1,955
$88.00
$172.04K
Brennan Troyen A
15 Jun 2021
EVP and Chief Medical Officer
Sold after exercise
67,552
$86.00
$5.81M
Finke Daniel P
7 Jun 2021
EVP/Pres, Health Care Benefits
Sold after exercise
37,594
$86.60
$3.26M
Moriarty Thomas M
10 May 2021
EVP & General Counsel
Sold after exercise
109,469
$86.00
$9.41M
Moriarty Thomas M
21 Apr 2021
EVP & General Counsel
Sold after exercise
2,420
$77.00
$186.34K
Moriarty Thomas M
21 Apr 2021
EVP & General Counsel
Sold after exercise
101,003
$77.00
$7.78M
Clark James David
31 Mar 2021
SVP, Cont & Chief Acct Officer
Sold after exercise
5,350
$76.00
$406.60K
Moriarty Thomas M
29 Mar 2021
EVP & General Counsel
Sold after exercise
62,943
$76.15
$4.79M
MERLO LARRY J
26 Mar 2021
Director
Sold after exercise
270,650
$74.73
$20.23M
Roberts Jonathan C
26 Mar 2021
EVP & Chief Operating Officer
Sold after exercise
73,433
$74.49
$5.47M
Boratto Eva C
16 Mar 2021
EVP & CFO
Sold after exercise
18,882
$74.68
$1.41M
MERLO LARRY J
19 Jan 2021
President and CEO
Sold after exercise
62,893
$77.00
$4.84M
Bisaccia Lisa
12 Jan 2021
EVP and Chief HR Officer
Sold after exercise
25,177
$77.00
$1.94M
Brennan Troyen A
8 Jan 2021
EVP and Chief Medical Officer
Sold after exercise
58,896
$75.00
$4.42M
Lotvin Alan
8 Jan 2021
EVP and President-CVS Caremark
Sold after exercise
25,836
$75.00
$1.94M
Flum Joshua Matthew
10 Nov 2020
EVP, ENT STRATEGY & DIGITAL
Sold after exercise
21,460
$70.00
$1.50M
Clark James David
30 Mar 2020
SVP, Cont & Chief Acct Officer
Sold after exercise
3,030
$60.00
$181.80K
MERLO LARRY J
15 Jan 2020
President and CEO
Sold after exercise
266,476
$74.79
$19.93M
Roberts Jonathan C
8 Jan 2020
EVP & Chief Operating Officer
Sold after exercise
57,563
$72.63
$4.18M
Brennan Troyen A
4 Nov 2019
EVP and Chief Medical Officer
Sold after exercise
23,604
$68.00
$1.61M
Flum Joshua Matthew
30 Sep 2019
EVP, ENT STRATEGY & DIGITAL
Sold after exercise
17,703
$63.00
$1.12M
Boratto Eva C
12 Sep 2019
EVP & CFO
Sold after exercise
8,130
$65.00
$528.45K
Clark James David
1 Mar 2019
SVP, Cont & Chief Acct Officer
Sold after exercise
1,664
$58.14
$96.74K
Roberts Jonathan C
1 Feb 2019
EVP & Chief Operating Officer
Sold after exercise
77,639
$64.54
$5.01M
MERLO LARRY J
1 Feb 2019
President and CEO
Sold after exercise
166,368
$64.51
$10.73M
MERLO LARRY J
8 Jan 2019
President and CEO
Sold after exercise
166,368
$69.04
$11.49M
Bisaccia Lisa
1 Oct 2018
EVP and Chief HR Officer
Sold after exercise
13,770
$80.00
$1.10M
Bisaccia Lisa
1 Oct 2018
EVP and Chief HR Officer
Sold after exercise
7,764
$80.00
$621.12K
Boratto Eva C
1 Oct 2018
EVP, Cont & Chief Acct Officer
Sold after exercise
4,426
$80.00
$354.08K
Boratto Eva C
17 Sep 2018
EVP, Cont & Chief Acct Officer
Sold after exercise
13,311
$77.16
$1.03M
Hourican Kevin
27 Aug 2018
EVP & President, CVS Pharmacy
Sold after exercise
8,564
$75.00
$642.30K
Foulkes Helena
16 Feb 2018
EVP & President-CVS Pharmacy
Sold after exercise
19,965
$71.04
$1.42M
Moriarty Thomas M
2 Oct 2017
EVP & General Counsel
Sold after exercise
20,547
$81.17
$1.67M
Roberts Jonathan C
18 Sep 2017
EVP & Chief Operating Officer
Sold after exercise
85,743
$83.14
$7.13M
Foulkes Helena
15 Sep 2017
EVP & President-CVS Pharmacy
Sold after exercise
39,340
$81.88
$3.22M
MERLO LARRY J
13 Sep 2017
President and CEO
Sold after exercise
241,150
$83.07
$20.03M
Moriarty Thomas M
11 Sep 2017
EVP & General Counsel
Sold after exercise
49,174
$79.61
$3.91M
Moriarty Thomas M
11 Sep 2017
EVP & General Counsel
Sold after exercise
41,093
$79.61
$3.27M
Denton David M
11 Sep 2017
EVP and CFO
Sold after exercise
108,183
$79.62
$8.61M
Denton David M
11 Sep 2017
EVP and CFO
Sold after exercise
105,040
$79.68
$8.37M
Denton David M
11 Sep 2017
EVP and CFO
Sold after exercise
23,855
$79.61
$1.90M
Foulkes Helena
26 Jun 2017
EVP, President-CVS Pharmacy
Sold after exercise
20,333
$80.00
$1.63M
Foulkes Helena
19 Jun 2017
EVP, President-CVS Pharmacy
Sold after exercise
20,332
$76.98
$1.57M
Denton David M
12 Jun 2017
EVP and CFO
Sold after exercise
230,510
$80.00
$18.44M
Brennan Troyen A
21 Mar 2017
EVP and Chief Medical Officer
Sold after exercise
7,212
$78.73
$567.80K
Brennan Troyen A
21 Mar 2017
EVP and Chief Medical Officer
Sold after exercise
16,637
$78.73
$1.31M
Boratto Eva C
17 Mar 2017
EVP, Cont & Chief Acct Officer
Sold after exercise
6,029
$79.60
$479.91K
Sussman Andrew
13 Mar 2017
EVP, Clinical Services
Sold after exercise
7,449
$80.40
$598.90K
Sussman Andrew
13 Mar 2017
EVP, Clinical Services
Sold after exercise
6,655
$80.40
$535.06K
Denton David M
10 Mar 2017
EVP and CFO
Sold after exercise
95,618
$80.68
$7.71M
Roberts Jonathan C
16 Feb 2017
EVP & President, CVS Caremark
Sold after exercise
61,196
$80.00
$4.90M
MERLO LARRY J
1 Feb 2017
President and CEO
Sold after exercise
76,494
$78.32
$5.99M

What was left out

Form 4 filings counted 595
Amendments (4/A) skipped 18
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 81
Sales at will 33
Transactions with no price 0
Shares from compensation/vesting 14,477,869
Sales filed before the plan box existed 15
History held since 4 Nov 2016